Oral Presentation ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Continuous subcutaneous hydrocortisone infusion (CSHI) in patients with adrenal insufficiency: a reflection of 14 years' experience. (#65)

Phillip Yeoh 1
  1. The London Clinic, LONDON, United Kingdom

This talk is focus on our experience of looking after patients with adrenal insufficiency (AI) in those who choose to use continuous subcutaneous hydrocortisone infusion as their treatment choice. We have over 50 people who started on CSHI with Addison's disease, secondary adrenal insufficiency, bilateral adrenalectomy, CAH, AI related to ACC, steroid induced AI and etc. This nurse-led service is to give people with AI some control over their lives. 80% of these participants continue to use this method of AI management. We reflected on the pros and cons of the treatment, and the recommendation for future practice.